Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Canopy Growth Corp T.WEED

Alternate Symbol(s):  T.WEED.DB | CGC

Canopy Growth Corporation is a cannabis company. It delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space, in addition to category-defining vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. International markets cannabis segment includes the production, distribution, and sale of a range of cannabis and hemp products internationally. Storz & Bickel segment includes the production, distribution, and sale of vaporizers. This Works segment includes the production, distribution and sale of beauty, skincare, wellness and sleep products.


TSX:WEED - Post by User

Bullboard Posts
Comment by FalconMon Dec 01, 2017 2:05pm
136 Views
Post# 27073886

RE:Senate Prediction

RE:Senate PredictionWhen I posted about the Senate I wanted to hear from people and get their risk assessment. There actually were some thoughtful posts that I respected. However, since then OGI has kicked it up a notch and while I thought the upside on OGI was limited, I was wrong. 130-140M in cash (almost half their market cap in cash - the highest proportion in the sector of market cap vs. cash), they have revenue report middle of the month, meanwhile the shorts have completely overextended themselves. Between Nov 15 and Nov 30, 33% of trades were short, the highest proportion of short activity among the major LPs, for ex. Aphria was only 15%. These guys will get squeezed because they are tryign to chase the negative momentum of the sector, but OGI has their rev. report, which is a major catalyst, so they have no real short game term game, especially given the likelihood that this quarter is going to show OGI is back on its two feet, beginning its second major long-term run.
Bullboard Posts